National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

rifabutin
A semisynthetic ansamycin antibiotic with potent antimycobacterial properties. Rifabutin inhibits bacterial DNA-dependent RNA polymerase, thereby suppressing the initiation of RNA formation and leading to inhibition of RNA synthesis and transcription. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Mycobutin



Previous:rhizoxin, ribavirin, riboflavin, ribosome-inactivating protein CY503, Riboxamide
Next:Rilutek, riluzole, risedronate sodium, Ritalin, ritonavir

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov